We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+41.13%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.25B
AUM Growth
+$548M
Cap. Flow
-$56.8M
Cap. Flow %
-1.75%
Top 10 Hldgs %
55.94%
Holding
98
New
6
Increased
21
Reduced
21
Closed
11

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$69.8M
2
ARQL
Arqule Inc
ARQL
+$40.8M
3
QURE icon
uniQure
QURE
+$35M
4
THC icon
Tenet Healthcare
THC
+$27M
5
AABA
Altaba Inc
AABA
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 18.43%
2 Consumer Discretionary 7.38%
3 Industrials 6.33%
4 Financials 5.02%
5 Technology 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMD icon
51
Viemed Healthcare
VMD
$371M
$9.38M 0.29%
1,498,100
SRL icon
52
Scully Royalty
SRL
$87.1M
$9.35M 0.29%
753,885
-83,163
-10% -$914K
FTACU
53
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
$9.11M 0.28%
842,730
RFL icon
54
Rafael Holdings
RFL
$107M
$8.66M 0.27%
492,161
SIGA icon
55
SIGA Technologies
SIGA
$219M
$8.4M 0.26%
1,760,764
-39,750
-2% -$202K
BRSL
56
CALL
Brightstar Lottery PLC
BRSL
$2.03B
$7.49M 0.23%
500,000
GYRE icon
57
Gyre Therapeutics
GYRE
$744M
$7.3M 0.22%
142,900
+1,188
+0.8% +$49.8K
LINC icon
58
Lincoln Educational Services
LINC
$1.3B
$7.07M 0.22%
2,436,805
NEOS
59
DELISTED
Neos Therapeutics, Inc
NEOS
$6.96M 0.21%
4,610,000
AFI
60
DELISTED
Armstrong Flooring, Inc.
AFI
$6.53M 0.2%
1,530,105
-107,619
-7% -$526K
SSKN
61
DELISTED
Strata Skin Sciences
SSKN
$6.06M 0.19%
285,100
TA
62
DELISTED
TravelCenters of America LLC
TA
$5.79M 0.18%
337,390
CEMI
63
DELISTED
Chembio diagnostics, Inc.
CEMI
$5.65M 0.17%
1,239,983
ZVO
64
DELISTED
Zovio Inc. Common Stock
ZVO
$5.46M 0.17%
2,653,087
+1,569,181
+145% +$3.14M
NATR icon
65
Nature's Sunshine
NATR
$288M
$5.33M 0.16%
597,310
+13,800
+2% +$130K
INSUU
66
DELISTED
Insurance Acquisition Corp. Unit
INSUU
$5.32M 0.16%
500,000
APEN
67
DELISTED
Apollo Endosurgery, Inc.
APEN
$5.28M 0.16%
1,810,562
XELA
68
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$5.21M 0.16%
1,065
ARYAU
69
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$5.21M 0.16%
452,944
GLMD icon
70
Galmed Pharmaceuticals
GLMD
$4.97M
$5.08M 0.16%
4,884
ACER
71
DELISTED
Acer Therapeutics Inc
ACER
$3.97M 0.12%
990,655
STRM
72
DELISTED
Streamline Health Solutions
STRM
$3.83M 0.12%
183,573
+66,220
+56% +$1.22M
RH icon
73
RH
RH
$3.71B
$3.8M 0.12%
17,793
-357,914
-95% -$69.8M
HTGM
74
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$3.51M 0.11%
27,778
EVRI
75
DELISTED
Everi Holdings
EVRI
$3.36M 0.1%
+250,000
New +$2.85M

Similar funds

Nantahala Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Nantahala Capital Management held 98 positions worth $3.25B, up 20% from $2.7B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management's Q4 2019 filing shows 6 new, 21 increased, 21 reduced and 11 closed positions. Its largest new stake was Franchise Group, Inc.: 1,910,247 shares worth $43.7M. The largest sale was RH, an estimated $69.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nantahala Capital Management's largest Q4 2019 buy was Franchise Group, Inc.: 1,910,247 shares worth $43.7M.
  • Nantahala Capital Management added most to SciPlay Corporation Class A Common Stock in Q4 2019, an estimated $7.29M increase.
  • Nantahala Capital Management's biggest Q4 2019 reduction was RH, cutting an estimated $69.8M.
  • Nantahala Capital Management fully exited Altaba Inc in Q4 2019, selling an estimated $17.2M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $3.25B portfolio in Q4 2019.
  • Nantahala Capital Management opened 6 new positions and closed 11 in Q4 2019.
  • Nantahala Capital Management's portfolio value rose 20% quarter-over-quarter to $3.25B.

Based on Nantahala Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.